S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda

Twist Bioscience (TWST) Earnings Date, Estimates & Call Transcripts

$27.95
-0.41 (-1.45%)
(As of 04/19/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 2
After Market Closes
Confirmed
Actual EPS
(Feb. 2)
-$0.75 Beat By $0.03
Consensus EPS
(Feb. 2)
-$0.78
Skip Charts & View Estimated and Actual Earnings Data

TWST Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TWST Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Twist Bioscience Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20243($1.20)($0.82)($0.97) 
Q2 20243($1.09)($0.81)($0.92) 
Q3 20243($0.92)($0.74)($0.83) 
Q4 20243($0.85)($0.72)($0.78) 
FY 202412($4.06)($3.09)($3.49) 
Q1 20251($0.80)($0.80)($0.80) 
Q2 20251($0.75)($0.75)($0.75) 
Q3 20251($0.68)($0.68)($0.68) 
Q4 20251($0.62)($0.62)($0.62) 
FY 20254($2.85)($2.85) ($2.85)

TWST Earnings Date and Information

Twist Bioscience last issued its quarterly earnings results on February 2nd, 2024. The reported ($0.75) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.78) by $0.03. The company had revenue of $71.50 million for the quarter, compared to analyst estimates of $67.59 million. Its quarterly revenue was up 31.8% compared to the same quarter last year. Twist Bioscience has generated ($3.61) earnings per share over the last year (($3.61) diluted earnings per share). Earnings for Twist Bioscience are expected to grow in the coming year, from ($3.17) to ($2.81) per share. Twist Bioscience has confirmed that its next quarterly earnings report will be published on Thursday, May 2nd, 2024. Twist Bioscience will be holding an earnings conference call on Thursday, May 2nd at 4:30 PM Eastern. Interested parties can register for or listen to the call..

Twist Bioscience Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/2/2024
Confirmed)
-------  
2/2/2024Q4 2023($0.78)($0.75)+$0.03($0.75)$67.59 million$71.50 million    
11/17/2023Q3 2023($0.92)($0.81)+$0.11($0.81)$63.35 million$66.95 million    
8/4/2023Q3 2023($1.14)($1.01)+$0.13($1.01)$60.62 million$63.80 million    
5/5/2023Q2 2023($1.09)($1.06)+$0.03($1.08)$56.61 million$60.18 million
2/3/2023Q1 2023($1.09)($0.74)+$0.35($0.74)$54.47 million$54.20 million    
11/18/2022Q4 2022($1.28)($0.91)+$0.37($0.91)$56.99 million$57.31 million
8/5/2022Q3 2022($1.30)($1.08)+$0.22($1.08)$52.06 million$56.10 million  
5/5/2022Q2 2022($1.26)($1.24)+$0.02($1.35)$45.25 million$48.13 million    
2/4/2022Q1 2022($1.08)($0.91)+$0.17($0.91)$38.22 million$42.00 million    
11/22/2021Q3 2021($0.80)($0.84)($0.04)($0.84)$36.26 million$37.95 million  
8/5/2021Q2 2021($0.75)($0.82)($0.07)($0.82)$32.43 million$35.02 million    
5/6/2021Q1 2021($0.76)($0.78)($0.02)($0.78)$28.18 million$31.20 million  

Twist Bioscience Earnings - Frequently Asked Questions

When is Twist Bioscience's earnings date?

Twist Bioscience has confirmed that its next quarterly earnings data will be published on Thursday, May 2nd, 2024. Learn more on TWST's earnings history.

Did Twist Bioscience beat their earnings estimates last quarter?

In the previous quarter, Twist Bioscience (NASDAQ:TWST) reported ($0.75) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.78) by $0.03. Learn more on analysts' earnings estimate vs. TWST's actual earnings.

How can I listen to Twist Bioscience's earnings conference call?

The conference call for Twist Bioscience's latest earnings report can be listened to online. Listen to Conference Call

How can I read Twist Bioscience's conference call transcript?

The conference call transcript for Twist Bioscience's latest earnings report can be read online. Read Transcript

How much revenue does Twist Bioscience generate each year?

Twist Bioscience (NASDAQ:TWST) has a recorded annual revenue of $245.11 million.

How much profit does Twist Bioscience generate each year?

Twist Bioscience (NASDAQ:TWST) has a recorded net income of -$204.62 million. TWST has generated -$3.61 earnings per share over the last four quarters.

What is Twist Bioscience's EPS forecast for next year?

Twist Bioscience's earnings are expected to grow from ($3.17) per share to ($2.81) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:TWST) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners